By Dr. Lisa Parker, DNP, APRN, NP | Parker Neuroscience | Omaha, Nebraska
When patients begin researching IV ketamine therapy, Spravato treatment, treatment-resistant depression, PTSD, or anxiety treatment, one of the most common terms they encounter is neuroplasticity.
The problem is that almost nobody explains what neuroplasticity actually means in a way that feels practical.
At Parker Neuroscience, we often talk with patients about neuroplasticity and ketamine in simple, human terms because the concept matters. Understanding how the brain forms patterns can help patients better understand why they may feel stuck and why treatment is often about creating the possibility for change, not forcing change overnight.
Key Takeaways
Neuroplasticity refers to the brain’s ability to form new connections.
According to Dr. Lisa Parker, neuroplasticity can be understood through the analogy of a forest trail that becomes easier to follow with repeated use.
Ketamine does not erase existing neural pathways.
Instead, it may create an opportunity for the brain to develop new pathways.
Lasting change still requires therapy, healthy habits, and active participation from the patient.
The Short Answer
Here is the simplest explanation I give my patients:
Imagine your brain as a forest.
Every thought you repeatedly think, every emotion you repeatedly experience, and every behavior you repeatedly engage in creates a path through that forest.
The more often you travel that path, the wider and easier it becomes to follow.
Eventually, your brain begins taking that route automatically.
That is neuroplasticity.
And it may explain why people with depression, anxiety, or trauma often describe feeling trapped in the same patterns, even when they desperately want change.
This is also why the relationship between neuroplasticity and ketamine has become an important topic in interventional psychiatry.
Why Depression Can Feel So Difficult to Escape
Many people assume depression is simply a matter of mindset.
In clinical practice, the reality is often far more complex.
When someone experiences depression for months or years, certain thought patterns can become deeply reinforced:
Hopelessness
Self-criticism
Emotional numbness
Withdrawal from relationships
Difficulty imagining a positive future
Over time, these mental pathways become familiar.
Not because they are helpful.
Because they are well-traveled.
Just as a hiker naturally follows the clearest trail through a forest, the brain often defaults to pathways it has used repeatedly.
This is one reason people with treatment-resistant depression frequently tell me:
“I know these thoughts aren’t helping me, but I can’t seem to stop having them.”
That experience is often not a failure of effort.
It may reflect how deeply established certain neural pathways have become.
The Same Principle Applies to PTSD and Anxiety
This concept is not limited to depression.
Patients struggling with PTSD may find themselves repeatedly returning to states of hypervigilance, fear, avoidance, or emotional reactivity.
Patients living with chronic anxiety may feel as though their minds automatically scan for danger, uncertainty, or worst-case scenarios.
Again, the issue is not weakness.
The brain is doing what brains are designed to do:
Follow familiar pathways.
The challenge arises when those pathways no longer serve the person living with them.
Where Ketamine Therapy Fits Into the Conversation
Research suggests that ketamine may temporarily increase the brain’s capacity to form new neural connections, which is one reason it has generated significant clinical interest for treatment-resistant depression and other psychiatric conditions. A systematic review published through the National Institutes of Health describes evidence that ketamine is associated with molecular changes involved in neuroplasticity and rapid antidepressant effects. Research on ketamine and neuroplasticity
However, I think there is an important misconception that deserves clarification.
Ketamine does not erase old pathways.
It does not delete difficult memories.
It does not magically replace years of emotional experience.
Returning to our forest analogy:
Ketamine does not remove the old trail.
Instead, it may make it easier to begin creating new ones.
That is why the conversation around neuroplasticity and ketamine should always include realistic expectations.
For many patients, this shift feels significant.
They may notice:
- Greater psychological flexibility
- Increased openness to therapy
- Improved ability to consider alternative perspectives
- Reconnection with relationships and activities they once enjoyed
- A reduced sense of feeling emotionally “stuck”
Those changes matter.
Not because the work is finished.
Because the work has become possible.
The Part Many People Miss
One of the conversations I frequently have with patients in Omaha who are exploring ketamine therapy or Spravato treatment is this:
Ketamine is not the entire treatment.
It is part of a larger process.
The brain’s increased flexibility creates an opportunity.
What happens next still matters.
Healthy habits matter.
Therapy matters.
Self-reflection matters.
Sleep matters.
Relationships matter.
The opportunity created by treatment must still be used.
The “Stuck Door” Analogy
Another analogy I often share with patients is this:
Imagine standing in front of a door that has been stuck shut for years.
You push.
Nothing happens.
You try again.
Still nothing.
Eventually, you stop trying because experience has taught you the door will not move.
For some patients, ketamine therapy can feel like finally loosening that door.
The door opens.
But you still decide whether to walk through it.
And once you do, you decide what comes next.
That is where meaningful and lasting change often begins.
What This Means for Patients Considering Treatment
Whether someone is exploring IV ketamine therapy, Spravato treatment, PTSD treatment, anxiety treatment, or options for treatment-resistant depression, understanding neuroplasticity and ketamine can help set realistic expectations.
The goal is not to become a different person overnight.
The goal is not to erase the past.
The goal is to create the possibility of new patterns, new perspectives, and new ways of responding to life’s challenges.
For many patients, that possibility is where hope returns.
And for some, it becomes the beginning of genuine healing.
Frequently Asked Questions
What is neuroplasticity?
Neuroplasticity refers to the brain’s ability to adapt, reorganize, and form new neural connections throughout life.
How are neuroplasticity and ketamine connected?
Research suggests ketamine may temporarily enhance the brain’s ability to form new connections, which may contribute to its therapeutic effects in some patients.
Can neuroplasticity help treatment-resistant depression?
Neuroplasticity is believed to play a role in how people develop new thought patterns, emotional responses, and behavioral habits that support recovery.
Can ketamine help PTSD?
Emerging research continues to investigate ketamine’s potential role in PTSD treatment. Eligibility should always be determined through a comprehensive clinical evaluation.
Is ketamine a cure for depression?
No. Ketamine is not a cure. It may create an opportunity for change, but lasting improvement often involves ongoing therapeutic, behavioral, and lifestyle work.
About Dr. Lisa Parker
Dr. Lisa Parker, DNP, APRN, NP, is the Founder and Clinical Director of Parker Neuroscience in Omaha, Nebraska. She specializes in interventional psychiatry, IV ketamine therapy, Spravato treatment, treatment-resistant depression, PTSD treatment, anxiety treatment, and psychiatric medication management.
With more than 20 years of clinical experience spanning emergency medicine and psychiatric care, Dr. Parker focuses on evidence-based treatment approaches for patients who have not achieved adequate relief through traditional therapies.
Areas of expertise include:
IV Ketamine Therapy
Spravato
Treatment-Resistant Depression
PTSD Treatment
Anxiety Treatment
Psychiatric Medication Management
Interventional Psychiatry
Learn more about Dr. Parker and Parker Neuroscience.